Stay updated with breaking news from Apexigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apexigen, Inc. (NASDAQ:APGN – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 64,500 shares, a decline of 18.8% from the July 15th total of 79,400 shares. Approximately 0.3% of the shares of the company are sold […] ....
Apexigen, Inc. (NASDAQ:APGNW – Get Free Report) was the target of a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 2,400 shares, a decrease of 36.8% from the June 15th total of 3,800 shares. Based on an average daily volume of 3,600 shares, the […] ....
Apexigen (NASDAQ:APGN – Get Rating) and Catalyst Biosciences (NASDAQ:CBIO – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Volatility and Risk Apexigen has a beta of 3.94, suggesting […] ....
- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in patients with dedifferentiated liposarcoma -. | June 3, 2023 ....
- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in. ....